Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · IEX Real-Time Price · USD
2.660
-0.040 (-1.48%)
At close: Jul 2, 2024, 4:00 PM
2.580
-0.080 (-3.01%)
After-hours: Jul 2, 2024, 4:06 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $352.64 million as of July 2, 2024. Its market cap has decreased by -21.44% in one year.
Market Cap
352.64M
Enterprise Value
379.52M
1-Year Change
-21.44%
Ranking
Category
Stock Price
$2.66
Market Cap Chart
Since January 5, 2017, Organogenesis Holdings's market cap has decreased from $376.60M to $352.64M, a decrease of -6.36%. That is a compound annual growth rate of -0.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 357.90M | -33.72% |
| Dec 29, 2023 | 540.00M | 53.32% |
| Dec 30, 2022 | 352.20M | -70.37% |
| Dec 31, 2021 | 1.19B | 46.45% |
| Dec 31, 2020 | 811.60M | 78.10% |
| Dec 31, 2019 | 455.70M | 30.13% |
| Dec 31, 2018 | 350.20M | -8.90% |
| Dec 29, 2017 | 384.40M | 2.07% |
| Jan 5, 2017 | 376.60M | - |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anika Therapeutics | 376.34M |
| Aura Biosciences | 374.55M |
| Fate Therapeutics | 373.37M |
| Pacific Biosciences of California | 373.13M |
| ModivCare | 372.89M |
| Lyell Immunopharma | 369.66M |
| Bioventus | 367.01M |
| Cabaletta Bio | 361.11M |